Hal Andrew Skopicki, MD, PhD, FACC
Assistant Professor of Medicine
Director, Heart Failure and Cardiomyopathy Program

SUNY-Stony Brook School of Medicine
Health Sciences Center T16-080
Stony Brook, NY 11794-8171
Phone: 631-444-1069
Fax: 631-444-2238
Email: hal.skopicki@stonybrook.edu
For Appointments: 631-444-9600

EDUCATION AND TRAINING

• BA, Brandeis University, Waltham, Massachusetts, BA, 1982
• PhD, Rosalind Franklin School of Medicine, North Chicago, IL, 1988
• MD, Rosalind Franklin School of Medicine, North Chicago, IL, 1990
• Residency in Internal Medicine, Yale-New Haven Hospital, New Haven, CT, 1990-1992
• Clinical and Research Fellow in Cardiology, Massachusetts General Hospital, Boston, MA, 1992-1995

BOARD CERTIFICATION

• American Board of Internal Medicine (1992; Recertified 2002)

AREAS OF CLINICAL EXPERTISE

• Heart failure
• Cardiomyopathy
• Valvular heart disease
• Heart failure of pregnancy

CURRENT RESEARCH INTERESTS

• Treatment and diagnosis of breathlessness and fatigue
• Treatment of advanced heart failure
• Cardiomyocyte development and cell cycle regulation
• Cell transplantation

SPECIAL ACCOMPLISHMENTS/RECENT PUBLICATIONS

• Rossof Lecturer in Pediatric Cardiology
• Young Investigator Award Finalist in Molecular & Cellular Biology, American College of Cardiology
• Board of Trustees Scholarship Award for meritorious academic achievement in clinical sciences
• John J. Sheinin Research Award for originality and creativity in research
• Alpha Omega Alpha Medical Honor Society
• Paul Dudley White Society
• Skopicki HA, Abraham SA, Weisman N, Mukerjee A, Alpert N, Fischman A, Picard M, Gewirtz H. Factors influencing regional myocardial contractile response to inotropic stimulation: analysis in humans with stable ischemic heart disease. Circulation. 94:643-50, 1996.
• Gewirtz H, Skopicki HA, Abraham SA, Castano H, Dinsmore RE, Alpert NM, FischmanAJ. Quantitive PET measurements of regional myocardial blood flow: observations in humans with ischemic heart disease. Cardiology. 88:62-70, 1997.
• Skopicki HA, Lyons G, Schatteman G, Smith RC, Schirm S, Isner JMI, Walsh K. Embryonic expression of a growth-arrest homeobox gene in cardiac, smooth and skeletal muscle lineages. Circ Res. 80:452-62, 1997.
• Skopicki HA, Abraham SA, Picard M, Alpert N, Fischman A, H Gewirtz H. Effects of dobutamine at maximally tolerated dose on myocardial blood flow in humans with ischemic heart disease. Circulation. 96:3346-52, 1997.
• Holmvang G, Fry S, Skopicki HA, Abraham SA, Alpert NM, Fischman AJ, Picard MH, Gewirtz H. Relationship between coronary “steal” and contractile function at rest in collateral dependent myocardium of humans with ischemic heart disease.” Circulation. 99:2510-6, 1999.
• Sridhar P, Liu Y, Chin LD, Borja CE, Mann M, Skopicki HA, Freter RR. Platelet derived growth factor-stimulated expression of the MCP-1 immediate-early gene involves an inhibitory multi-protein complex. Mol Cell Biol. 19:4219-30, 1999.
• Fard A, Wang CY, Takuma S, Skopicki HA, Pinsky DJ, DiTullio MR, Homma S. Necropsy validation of changes in LV mass in ascending aortic banded mice from 2-dimensional echocardiographic images. J Am Soc Echocardiogr. 13(6):582-7, 2000.
• Tawakol A, Skopicki HA, Abraham SA, Alpert NM, Fischman AJ, Picard MH, Gewirtz H. Evidence of reduced resting blood flow in viable myocardial segments with chronic asynergy. J Am Coll Cardiol. 36:2146-53, 2000.
• Chia KK, Picard MH, Skopicki HA, Hung J. Viability of hypokinetic segments: influence of tethering from adjacent segments: influence of tethering from adjacent segments. Echocardiography. 2002;19(6):475-81.
• Sackner-Bernstein JD, Skopicki HA. Racing away from bias. J Am Coll Cardiol. 2004;43:785-6.
• Hwang YC, Kaneko M, Bakr S, Liao H, Lu Y, Lewis ER, Yan S, Ii S, Itakura M, Rui L, Skopicki H, Homma S, Schmidt AM, Szabolcs M, Ramasamy R. Central role for aldose reductase pathway in myocardial ischemic injury. FASEB J. 2004;18:1192-9.
• Sackner-Bernstein JD, Skopicki HA, Aaronson KD. Risk of worsening renal function with nesiritide in patients with acutely decompensated heart failure. Circulation. 2005;111:1487-91.
• Lin X, Sakuragi T, Metz CN, Ojamaa K, Skopicki HA, Wang P, Al-Abed Y, Miller EJ. Macrophage migration inhibitory factor within the alveolar spaces induces changes in the heart during late experimental sepsis. Shock. 2005;24:556-63.